SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
¶
– Release Delayed ·As Of Filer Filing For·On·As Docs:Size Issuer Agent 6/11/18 AVROBIO, Inc. S-1/A¶ 18:5.4M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: S-1/A Pre-Effective Amendment to Registration Statement HTML 1.63M (General Form) 18: CORRESP ¶ Comment-Response or Other Letter to the SEC HTML 22K 2: EX-1.1 Underwriting Agreement HTML 161K 3: EX-3.2 Articles of Incorporation/Organization or By-Laws HTML 12K 4: EX-3.3 Articles of Incorporation/Organization or By-Laws HTML 27K 5: EX-3.5 Articles of Incorporation/Organization or By-Laws HTML 94K 6: EX-4.1 Instrument Defining the Rights of Security Holders HTML 18K 7: EX-5.1 Opinion re: Legality HTML 11K 13: EX-10.10 Material Contract HTML 62K 14: EX-10.11 Material Contract HTML 67K 15: EX-10.14 Material Contract HTML 31K 8: EX-10.2 Material Contract HTML 201K 9: EX-10.3 Material Contract HTML 16K 10: EX-10.4 Material Contract HTML 129K 11: EX-10.6 Material Contract HTML 107K 12: EX-10.9 Material Contract HTML 62K 16: EX-23.1 Consent of Experts or Counsel HTML 8K 17: EX-99.1 Miscellaneous Exhibit HTML 8K
EX-5.1 |
Exhibit 5.1
AVROBIO, Inc.
One Kendall Square
Building 300, Suite 201
Re: | Securities Registered under Registration Statement on Form S-1 |
Ladies and Gentlemen:
We have acted as counsel to you in connection with your filing of a Registration Statement on Form S-1 (File No. 333-225213) (as amended or supplemented, the “Registration Statement”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”), relating to the registration of the offering by AVROBIO, Inc., a Delaware corporation (the “Company”), of up to 5,073,800 shares (the “Shares”) of the Company’s Common Stock, $0.0001 par value per share, including Shares purchasable by the underwriters upon their exercise of an over-allotment option granted to the underwriters by the Company. The Shares are being sold to the several underwriters named in, and pursuant to, an underwriting agreement among the Company and such underwriters (the “Underwriting Agreement”).
We have reviewed such documents and made such examination of law as we have deemed appropriate to give the opinions set forth below. We have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinions set forth below, on certificates of officers of the Company.
The opinion set forth below is limited to the Delaware General Corporation Law.
Based on the foregoing, we are of the opinion that the Shares have been duly authorized and, upon issuance and delivery against payment therefor in accordance with the terms of the Underwriting Agreement, the Shares will be validly issued, fully paid and non-assessable.
We hereby consent to the inclusion of this opinion as Exhibit 5.1 to the Registration Statement and to the references to our firm under the caption “Legal Matters” in the Registration Statement. In giving our consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.
Very truly yours, |
/s/ Goodwin Procter LLP |
GOODWIN PROCTER LLP |
This ‘S-1/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 6/11/18 | None on these Dates | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/29/24 AVROBIO, Inc. S-4/A 80:15M Donnelley … Solutions/FA 4/15/24 AVROBIO, Inc. S-4/A 91:17M Donnelley … Solutions/FA 3/26/24 AVROBIO, Inc. S-4/A 3/25/24 89:18M Donnelley … Solutions/FA 3/14/24 AVROBIO, Inc. 10-K 12/31/23 80:9.4M Donnelley … Solutions/FA 2/14/24 AVROBIO, Inc. S-4 91:25M Donnelley … Solutions/FA 3/23/23 AVROBIO, Inc. S-8 3/23/23 4:65K Broadridge Fin’l So… Inc 3/23/23 AVROBIO, Inc. 10-K 12/31/22 82:10M Donnelley … Solutions/FA 11/08/22 AVROBIO, Inc. S-3 8:1.8M Broadridge Fin’l So… Inc 8/09/22 AVROBIO, Inc. S-8 8/09/22 4:62K Broadridge Fin’l So… Inc 3/17/22 AVROBIO, Inc. 10-K 12/31/21 78:9.1M ActiveDisclosure/FA 3/17/22 AVROBIO, Inc. S-8 3/17/22 4:62K Donnelley … Solutions/FA 3/18/21 AVROBIO, Inc. 10-K 12/31/20 73:9.1M ActiveDisclosure/FA 8/06/20 AVROBIO, Inc. S-8 8/06/20 3:50K Donnelley … Solutions/FA |